Glenmark Pharmaceuticals Schedules Q2 FY27 Earnings Call for November 2026
Glenmark Pharmaceuticals Ltd 路 Intimation 路 06 Nov 2026, 8:30 am
Glenmark Pharmaceuticals Schedules Q2 FY27 Earnings Call for November 2026 Glenmark Pharmaceuticals Limited has scheduled its earnings conference call on 6th Nov'26 from 8:30 am to 9:30 am IST to discuss the unaudited financial results for the quarter ended 30th Sep'26 (Q2 FY27). Universal dial-in numbers include +91 22 6280 1298 and +91 22 7115 8199, alongside international toll-free access for the USA, UK, Singapore, and Hong Kong.
Original exchange filing (PDF)
More announcements from Glenmark Pharmaceuticals Ltd
- Ichnos Glenmark Innovation (IGI) announces IND submission to US FDA for ISB 2301 路 18 Nov 2026
- Glenmark Pharmaceuticals Inc., USA Launches Authorised Generic of INLYTA (axitinib) Tablets, 1 mg and 5mg 路 16 Nov 2026
- Schedule of Schedule of Analyst/ Institutional Investor Meetings 路 10 Nov 2026
- Initmation of Schedule of Analyst/ Institutional Investor Meetings 路 10 Nov 2026
- Intimation of Schedule of Analyst/ Institutional Investor Meetings 路 10 Nov 2026
- Intimation of Schedule of Analyst / Institutional Investor Meetings 路 10 Nov 2026
- Transcript of the Earnings Call 路 09 Nov 2026
- Audio recording of Q2 FY 2026-27 Earnings Call held on November 06, 2026 路 06 Nov 2026
